Injectable bone cement (IBC) is a class of materials that are initially in either liquid or paste form, which can then either be injected through a channel or molded into shape. Injectable bone cements are biocompatible materials that can be used as bone defect fillers in maxillofacial surgeries and in orthopedic fracture treatment in order to augment weakened bone due to osteoporosis. Current clinically available IBCs, such as polymethylmethacrylate and calcium phosphate cement, have certain advantages; however, they possess several drawbacks that prevent them from gaining universal acceptance.
MARKET DYNAMICS
The injectable bone graft market is owing to increase due to advancement of new technology. Moreover, rising geriatric population and increasing incidence are driving the market growth in the forecast period.
MARKET SCOPE
The "Injectable Bone Graft Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of injectable bone graft market with detailed market segmentation by type, application, end user. The injectable bone graft market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in injectable bone graft market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The injectable bone graft market is segmented on the basis of type, application and end user. Based on type the market is segmented as bone morphogenic proteins (BMP) and synthetic bone grafts. On the basis of application, the market is categorized as joint reconstruction, spinal fusion, dental bone grafting, craniomaxillofacial, foot and ankle and long bone. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers, emergency rooms and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the injectable bone graft market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The injectable bone graft market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting injectable bone graft market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the injectable bone graft market in these regions.
MARKET PLAYERS
The report covers key developments in the injectable bone graft market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from injectable bone graft market are anticipated to have lucrative growth opportunities in the future with the rising demand for injectable bone graft in the global market. Below mentioned is the list of few companies engaged in the injectable bone graft market.
The report also includes the profiles of key players in injectable bone graft market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AlloSource, Inc.,
- Biomatlante
- DePuy Synthes
- Graftys
- Medtronic PLC
- Nuvasive, Inc.,
- Orthofix Holdings, Inc.,
- Smith & Nephew
- Stryker Corporation
- Wright Medical Group N.V.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.